<?xml version="1.0" encoding="UTF-8"?>
<p>There is a compelling need to control the greatest global health crisis by COVID‐19 outbreak. Currently, there is no reliable therapeutic options for critically ill COVID‐19 contracted patients. Based on the consolidated clinical data derived from five independent studies of 27 patients suggests, in addition to antiviral/antimicrobial drugs, CPT could be an effective therapeutic option with promising evidence on safety, improvement of clinical symptoms, and reduced mortality. We recognize that a definitive conclusion cannot be drawn on optimal doses and treatment time point for the CPT to COVID‐19, a large multicenter clinical trials are urgently needed to tackle this pandemic.</p>
